Log In
BCIQ
Print this Print this
 

Insugen R

  Manage Alerts
Collapse Summary General Information
Company Biocon Ltd.
DescriptionShort-acting biosimilar recombinant human insulin
Molecular Target
Mechanism of ActionBiosimilar
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationDiabetes
Indication DetailsTreat Type I diabetes
Regulatory Designation
PartnerLaboratorios PiSA

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/17/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today